ArticleFrontiers in neurology2021

Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine.

Marcello Silvestro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.